Immunoassay of the adenosine deaminase complexing proteins of human tissues and body fluids.
A sensitive immunoassay for the adenosine deaminase binding protein (complexing protein) of human kidney has been developed. Impetus for the development of the assay was provided by the observations that (a) antibody to complexing protein does not react with the catalytically active adenosine deaminase monomer, and (b) binding of antibody to complexing protein does not affect the binding or catalytic activity of the enzyme monomer. Preformed immune precipitate prepared from rabbit anti-kidney complexing protein serum and goat anti-rabbit gamma-globulin serum is used to selectively insolubilize complexing protein. Quantitation is accomplished by measuring the intrinsic adenosine deaminating activity or adenosine deaminase binding capacity of the protein held in the immune precipitate. As little as 1 ng of kidney complexing protein can be accurately quantitated with the assay. The assay was used to demonstrate that complexing proteins from liver, lung, spleen, fibroblasts, plasma, and urine react with antibody to kidney complexing protein. The shared capacity to bind adenosine deaminase coupled with their antigenic similarity suggests that the complexing proteins of a number of human tissues and body fluids may be products of the same gene.
D000243:Adenosine Deaminase / Q000032:analysis*; D000906:Antibodies; D002352:Carrier Proteins / Q000032:analysis*; D006801:Humans; D007118:Immunoassay; D007668:Kidney / Q000201:enzymology*; D008970:Molecular Weight; D009700:Nucleoside Deaminases / Q000032:analysis*; D014018:Tissue Distribution
D000906:Antibodies; D002352:Carrier Proteins; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase